000 | 01032 a2200289 4500 | ||
---|---|---|---|
005 | 20250513150428.0 | ||
264 | 0 | _c19980917 | |
008 | 199809s 0 0 eng d | ||
022 | _a0008-6312 | ||
024 | 7 |
_a10.1159/000006808 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPool, P E | |
245 | 0 | 0 |
_aNeurohormonal activation in the treatment of congestive heart failure: basis for new treatments? _h[electronic resource] |
260 |
_bCardiology _cJul 1998 |
||
300 |
_a1-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 |
_aHeart Failure _xdrug therapy |
650 | 0 | 4 |
_aHormones _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMibefradil |
650 | 0 | 4 |
_aNeurotransmitter Agents _xphysiology |
650 | 0 | 4 |
_aTetrahydronaphthalenes _xtherapeutic use |
773 | 0 |
_tCardiology _gvol. 90 _gno. 1 _gp. 1-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1159/000006808 _zAvailable from publisher's website |
999 |
_c9658814 _d9658814 |